ARTICLE | Clinical News
Oral Taigexyn nemonoxacin regulatory update
March 17, 2014 7:00 AM UTC
TaiGen said the Taiwan Food and Drug Administration (TFDA) approved an NDA for oral Taigexyn nemonoxacin to treat communityacquired bacterial pneumonia (CABP). The non-fluorinated quinolone antibiotic...